Skip to main content

Inherited Cardiac Muscle Disorders: Arrhythmogenic Right Ventricular Cardiomyopathy

  • Chapter
  • First Online:
Cardiovascular Genetics and Genomics
  • 1317 Accesses

Abstract

Arrhythmogenic Cardiomyopathy (AC) is characterized by cardiomyocyte death with fibro-fatty repair, clinically manifesting with palpitations, syncope or cardiac arrest usually in adolescence or young adulthood. AC represents one of the major causes of sudden death in the young and athletes. The estimated prevalence of AC in the general population ranges from 1:2000 to 1:5000. AC affects more frequently males than females (up to 3:1), despite a similar prevalence of carrier status, and due to age-related penetrance becomes clinically overt most often in the second-fourth decade of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129–33.

    Article  CAS  PubMed  Google Scholar 

  2. Basso C, Thiene G, Corrado D, et al. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation. 1996;94:983–91.

    Article  CAS  PubMed  Google Scholar 

  3. Basso C, Corrado D, Marcus FI, et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373:1289–300.

    Article  PubMed  Google Scholar 

  4. Basso C, Bauce B, Corrado D, et al. Pathophysiology of arrhythmogenic cardiomyopathy. Nat Rev Cardiol. 2011;9:223–33.

    Article  PubMed  Google Scholar 

  5. Nava A, Bauce B, Basso C, et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2000;36:2226–33.

    Article  CAS  PubMed  Google Scholar 

  6. Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296:1593–601.

    Article  CAS  PubMed  Google Scholar 

  7. Pilichou K, Thiene G, Bauce B, et al. Arrhythmogenic cardiomyopathy. Orphanet J Rare Dis. 2016;11:33.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Pilichou K, Mancini M, Rigato I, et al. Nonischemic left ventricular scar: sporadic or familial? Screen the genes, scan the mutation carriers. Circulation. 2014;130:e180–2.

    Article  PubMed  Google Scholar 

  9. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Circulation. 2010;121:1533–41.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Basso C, Corrado D, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: what’s in a name? From a congenital defect (dysplasia) to a genetically determined cardiomyopathy (dystrophy). Am J Cardiol. 2010;106:275–7.

    Article  PubMed  Google Scholar 

  11. Uhl HS. A previously undescribed congenital malformation of the heart: almost total absence of the myocardium of the right ventricle. Bull Johns Hopkins Hosp. 1952;91:197–209.

    CAS  PubMed  Google Scholar 

  12. Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia – recent advances. Milano: Springer; 2007.

    Google Scholar 

  13. Basso C, Burke M, Fornes P, Association for European Cardiovascular Pathology, et al. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch. 2008;452:11–8.

    Article  PubMed  Google Scholar 

  14. Thiene G. The research venture in arrhythmogenic right ventricular cardiomyopathy: a paradigm of translational medicine. Eur Heart J. 2015;36:837–46.

    Article  PubMed  Google Scholar 

  15. Mallat Z, Tedgui A, Fontaliran F, et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med. 1996;335:1190–6.

    Article  CAS  PubMed  Google Scholar 

  16. Valente M, Calabrese F, Thiene G, et al. In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am J Pathol. 1998;152:479–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Pilichou K, Remme CA, Basso C, et al. Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy. J Exp Med. 2009;206:1787–802.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Calabrese F, Basso C, Carturan E, et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses? Cardiovasc Pathol. 2006;15:11–7.

    Article  PubMed  Google Scholar 

  19. Thiene G, Nava A, Angelini A, et al. Anatomoclinical aspects of arrhythmogenic right ventricular cardiomyopathy. In: Baroldi G, Camerini F, Goodwin JF, editors. Advances in cardiomyopathies. Berlin: Springer Verlag; 1990. p. 397–408.

    Chapter  Google Scholar 

  20. Basso C, Corrado D, Bauce B, et al. Arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2012;5:1233–46.

    Article  PubMed  Google Scholar 

  21. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339:364–9.

    Article  CAS  PubMed  Google Scholar 

  22. Rizzo S, Lodder EM, Verkerk AO, et al. Intercalated disc abnormalities, reduced Na(+) current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes. Cardiovasc Res. 2012;95:409–18.

    Article  CAS  PubMed  Google Scholar 

  23. Cerrone M, Noorman M, Lin X, et al. Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency. Cardiovasc Res. 2012;95:460–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J. 1994;71:215–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Migliore F, Zorzi A, Michieli P, et al. Prevalence of cardiomyopathy in Italian asymptomatic children with electrocardiographic T-wave inversion at preparticipation screening. Circulation. 2012;125:529–38.

    Article  PubMed  Google Scholar 

  26. Daliento L, Turrini P, Nava A, et al. Arrhythmogenic right ventricular cardiomyopathy in young versus adult patients: similarities and differences. J Am Coll Cardiol. 1995;25:655–64.

    Article  CAS  PubMed  Google Scholar 

  27. Bauce B, Basso C, Rampazzo A, et al. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J. 2005;26:1666–75.

    Article  CAS  PubMed  Google Scholar 

  28. Migliore F, Zorzi A, Silvano M, et al. Clinical management of arrhythmogenic right ventricular cardiomyopathy: an update. Curr Pharm Des. 2010;16:2918–28.

    Article  CAS  PubMed  Google Scholar 

  29. Perazzolo Marra M, Leoni L, Bauce B, et al. Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ Arrhythm Electrophysiol. 2012;5:91–100.

    Article  Google Scholar 

  30. di Gioia CR, Giordano C, Cerbelli B, Pisano A, Perli E, De Dominicis E, Poscolieri B, Palmieri V, Ciallella C, Zeppilli P, d’Amati G. Nonischemic left ventricular scar and cardiac sudden death in the young. Hum Pathol. 2016;58:78–89.

    Article  PubMed  Google Scholar 

  31. Basso C, Ronco F, Marcus F, et al. Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria. Eur Heart J. 2008;29:2760–71.

    Article  PubMed  Google Scholar 

  32. Corrado D, Basso C, Leoni L, et al. Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. J Am Coll Cardiol. 2008;51:731–9.

    Article  PubMed  Google Scholar 

  33. Migliore F, Zorzi A, Silvano M, et al. Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Arrhythm Electrophysiol. 2013;6:167–76.

    Article  PubMed  Google Scholar 

  34. Rigato I, Corrado D, Basso C, et al. Pharmacotherapy and other therapeutic modalities for managing arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Drugs Ther. 2015;29:171–7.

    Article  CAS  PubMed  Google Scholar 

  35. Wichter T, Paul TM, Eckardt L, et al. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD? Herz. 2005;30:91–101.

    Article  PubMed  Google Scholar 

  36. Corrado D, Leoni L, Link MS, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084–91.

    Article  PubMed  Google Scholar 

  37. Garcia FC, Bazan V, Zado ES, et al. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2009;120:366–75.

    Article  PubMed  Google Scholar 

  38. Corrado D, Calkins H, Link MS, et al. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation. 2010;122:1144–52.

    Article  PubMed  Google Scholar 

  39. Corrado D, Wichter T, Link MS, et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. Circulation. 2015;132:441–53.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Bauce B, Daliento L, Frigo G, et al. Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Obstet Gynecol Reprod Biol. 2006;127:186–9.

    Article  PubMed  Google Scholar 

  41. Nava A, Thiene G, Canciani B, et al. Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol. 1988;12:1222–8.

    Article  CAS  PubMed  Google Scholar 

  42. Protonotarios N, Tsatsopoulou A, Patsourakos P, et al. Cardiac abnormalities in familial palmoplantar keratosis. Br Heart J. 1986;56:321–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. McKoy G, Protonotarios N, Crosby A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet. 2000;355:2119–24.

    Article  CAS  PubMed  Google Scholar 

  44. Norgett EE, Hatsell SJ, Carvajal-Huerta L, et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet. 2000;9:2761–6.

    Article  CAS  PubMed  Google Scholar 

  45. Rampazzo A, Nava A, Malacrida S, et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 2002;71:1200–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Gerull B, Heuser A, Wichter T, et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet. 2005;37:106.

    Article  CAS  Google Scholar 

  47. Pilichou K, Nava A, Basso C, et al. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation. 2006;113:1171–9.

    Article  CAS  PubMed  Google Scholar 

  48. Syrris P, Ward D, Evans A, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet. 2006;79:978–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Asimaki A, Syrris P, Wichter T, et al. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 2007;81:964–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Merner ND, Hodgkinson KA, Haywood AF, et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet. 2008;82:809–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. van Tintelen JP, Van Gelder IC, Asimaki A, et al. Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. Heart Rhythm. 2009;6:1574–83.

    Article  PubMed  Google Scholar 

  52. van der Zwaag PA, Cox MG, van der Werf C, et al. Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Neth Hear J. 2010;18:583–91.

    Article  Google Scholar 

  53. Taylor M, Graw S, Sinagra G, et al. Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation. 2011;124:876–85.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Quarta G, Syrris P, Ashworth M, et al. Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2012;33:1128–36.

    Article  CAS  PubMed  Google Scholar 

  55. van Hengel J, Calore M, Bauce B, et al. Mutations in the area composita protein αT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2013;34:201–10.

    Article  PubMed  Google Scholar 

  56. Ortiz-Genga MF, Cuenca S, Dal Ferro M, et al. Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies. J Am Coll Cardiol. 2016;68:2440–51.

    Article  CAS  PubMed  Google Scholar 

  57. Mayosi BM, Fish M, Shaboodien G, et al. Identification of cadherin 2 (CDH2) mutations in arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet. 2017;10:e001605.

    Article  CAS  PubMed  Google Scholar 

  58. Beffagna G, Occhi G, Nava A, et al. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res. 2005;65:366–73.

    Article  CAS  PubMed  Google Scholar 

  59. Tiso N, Stephan DA, Nava A, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 2001;10:189–94.

    Article  CAS  PubMed  Google Scholar 

  60. Franke WW, Borrmann CM, Grund C, Pieperhoff S. The area composita of adhering junctions connecting heart muscle cells of vertebrates. I. Molecular definition in intercalated disks of cardiomyocytes by immunoelectron microscopy of desmosomal proteins. Eur J Cell Biol. 2006;85:69–82.

    Article  CAS  PubMed  Google Scholar 

  61. Turkowski KL, Tester DJ, Bos JM, Haugaa KH, Ackerman MJ. Whole exome sequencing with genomic triangulation implicates CDH2-encoded N-cadherin as a novel pathogenic substrate for arrhythmogenic cardiomyopathy. Congenit Heart Dis. 2017;12:226–35.

    Article  PubMed  Google Scholar 

  62. Bauce B, Nava A, Beffagna G, et al. Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 2010;7:22–9.

    Article  PubMed  Google Scholar 

  63. Rigato I, Bauce B, Rampazzo A, et al. Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet. 2013;6:533–42.

    Article  CAS  PubMed  Google Scholar 

  64. Xu T, Yang Z, Vatta M, Multidisciplinary Study of Right Ventricular Dysplasia Investigators, et al. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2010;55:587–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Lazzarini E, Jongbloed JD, Pilichou K, et al. The ARVD/C genetic variants database: 2014 update. Hum Mutat. 2015;36:403–10.

    Article  CAS  PubMed  Google Scholar 

  66. Bhonsale A, Groeneweg JA, James CA, et al. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. Eur Heart J. 2015;36:847–55.

    Article  CAS  PubMed  Google Scholar 

  67. Cox MG, van der Zwaag PA, van der Werf C, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study. Circulation. 2011;123:2690–700.

    Article  PubMed  Google Scholar 

  68. Richards S, Aziz N, Bale S, ACMG Laboratory Quality Assurance Committee, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Xu Z, Zhu W, Wang C, et al. Genotype-phenotype relationship in patients with arrhythmogenic right ventricular cardiomyopathy caused by desmosomal gene mutations: a systematic review and meta-analysis. Sci Rep. 2017;7:41387.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Dalal D, James C, Devanagondi R, et al. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2006;48:1416–24.

    Article  CAS  PubMed  Google Scholar 

  71. van Tintelen JP, Entius MM, Bhuiyan ZA, Jongbloed R, Wiesfeld AC, Wilde AA, et al. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation. 2006;113:1650–8.

    Article  PubMed  Google Scholar 

  72. Quarta G, Muir A, Pantazis A, Syrris P, Gehmlich K, Garcia-Pavia P, et al. Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria. Circulation. 2011;123:2701–9.

    Article  PubMed  Google Scholar 

  73. Fressart V, Duthoit G, Donal E, Probst V, Deharo JC, Chevalier P, et al. Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/ cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace. 2010;12:861–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kalliopi Pilichou .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pilichou, K., Bauce, B., Thiene, G., Basso, C. (2018). Inherited Cardiac Muscle Disorders: Arrhythmogenic Right Ventricular Cardiomyopathy. In: Kumar, D., Elliott, P. (eds) Cardiovascular Genetics and Genomics. Springer, Cham. https://doi.org/10.1007/978-3-319-66114-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-66114-8_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-66112-4

  • Online ISBN: 978-3-319-66114-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics